Shionogi to acquire IntraBio for $2 billion in rare disease push

🌐 Investing.com (Cyprus) —
Shionogi to acquire IntraBio for $2 billion in rare disease push

AI Summary

Shionogi plans to acquire IntraBio for $2 billion as it expands its presence in rare diseases. The transaction is a major pharmaceutical deal centered on IntraBio's rare-disease business.

Markets Deals Health Shionogi IntraBio acquisition rare diseases $2 billion pharmaceuticals

Read original source →